{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:14:39Z","timestamp":1739855679604,"version":"3.37.3"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,14]]},"abstract":"<jats:p>The causal relationship between inflammatory bowel disease (IBD) and diabetes mellitus remains unclear. The aim of this study was to delve into this association and investigate the correlation between AMP-activated protein kinase (AMPK), a target gene of metformin, and the risk of developing IBD. Researchers conducted a bidirectional two-sample Mendelian randomization analysis to examine causal relationships between IBD, including ulcerative colitis and Crohn disease (CD), and diabetes mellitus, encompassing both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Additionally, this study utilized AMPK-related variants associated with HbA1c (%) as instrumental variables for the metformin target gene AMPK to further investigate their association with the risk of IBD. The inverse variance weighted method was used as the primary analytical approach. Mendelian randomization analysis revealed a suggestive association between IBD and T1DM (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.024). CD was associated with an increased risk of T1DM (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.011). In the reverse analysis, T1DM also increased the risk of IBD (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.043). No causal relationship was found between IBD and T2DM in either the forward or reverse analyses. In addition, this study did not find any significant effect of AMPK on IBD. In conclusion, this study suggests a bidirectional association between IBD and T1DM, in which CD may increase the risk of T1DM. However, no causal relationship was found between IBD and T2DM. Furthermore, our findings revealed that the metformin\u2019s target gene AMPK had no significant effect on the onset of IBD.<\/jats:p>","DOI":"10.1097\/md.0000000000041532","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:01:17Z","timestamp":1739818877000},"page":"e41532","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes mellitus, metformin\u2019s target gene AMPK, and inflammatory bowel disease: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Chun\u2019an First People\u2019s Hospital (Chun\u2019an Branch of Zhejiang Provincial People\u2019s Hospital), Hangzhou, Zhejiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huomu","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Chun\u2019an First People\u2019s Hospital (Chun\u2019an Branch of Zhejiang Provincial People\u2019s Hospital), Hangzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunsheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chun\u2019an First People\u2019s Hospital (Chun\u2019an Branch of Zhejiang Provincial People\u2019s Hospital), Hangzhou, Zhejiang Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-0198","authenticated-orcid":false,"given":"Jia","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Chun\u2019an First People\u2019s Hospital (Chun\u2019an Branch of Zhejiang Provincial People\u2019s Hospital), Hangzhou, Zhejiang Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250217","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"R2-20250217","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease.","volume":"18","author":"Kaplan","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20250217","doi-asserted-by":"crossref","first-page":"264","DOI":"10.15171\/jnp.2017.42","article-title":"Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta-analysis.","volume":"6","author":"Ganji-Arjenaki","year":"2017","journal-title":"J Nephropathol"},{"key":"R4-20250217","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management.","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"R5-20250217","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn\u2019s disease and ulcerative colitis: a study of 700 patients.","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"R6-20250217","doi-asserted-by":"crossref","first-page":"11746","DOI":"10.1016\/j.jns.2021.117426","article-title":"Neurology of inflammatory bowel disease.","volume":"424","author":"Ferro","year":"2021","journal-title":"J Neurol Sci"},{"key":"R7-20250217","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jgh.14872","article-title":"The epidemiology of inflammatory bowel disease: east meets west.","volume":"35","author":"Mak","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-20250217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1026629528233","article-title":"Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.","volume":"44","author":"Das","year":"1999","journal-title":"Dig Dis Sci"},{"key":"R9-20250217","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence.","volume":"15","author":"Ananthakrishnan","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R10-20250217","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"R11-20250217","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ibd.20406","article-title":"Autoimmune disease concomitance among inflammatory bowel disease patients in the united states, 2001\u20132002.","volume":"14","author":"Cohen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R12-20250217","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/jcm8030343","article-title":"Increased risk of diabetes in inflammatory bowel disease patients: a nationwide population-based study in Korea.","volume":"8","author":"Kang","year":"2019","journal-title":"J Clin Med"},{"key":"R13-20250217","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cgh.2019.07.052","article-title":"Inflammatory bowel diseases increase risk of type 2 diabetes in a nationwide cohort study.","volume":"18","author":"Jess","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-20250217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R15-20250217","doi-asserted-by":"crossref","first-page":"m1203","DOI":"10.1136\/bmj.m1203","article-title":"Use of genetic variation to separate the effects of early and later life adiposity on disease risk: Mendelian randomisation study.","volume":"369","author":"Richardson","year":"2020","journal-title":"Bmj"},{"key":"R16-20250217","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1210\/jc.2009-1064","article-title":"Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach.","volume":"95","author":"Welsh","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20250217","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"R18-20250217","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"key":"R19-20250217","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet"},{"key":"R20-20250217","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00125-020-05243-z","article-title":"Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study.","volume":"63","author":"Luo","year":"2020","journal-title":"Diabetologia"},{"key":"R21-20250217","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5808\/GI.2016.14.4.173","article-title":"Comparison of two meta-analysis methods: Inverse-variance-weighted average and weighted sum of z-scores.","volume":"14","author":"Lee","year":"2016","journal-title":"Genomics Inform"},{"key":"R22-20250217","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R23-20250217","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/apa.15643","article-title":"Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes.","volume":"110","author":"Jasser-Nitsche","year":"2020","journal-title":"Acta Paediatr"},{"key":"R24-20250217","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15403\/jgld-798","article-title":"Epidemiologic association between inflammatory bowel diseases and type 1 diabetes mellitus: a meta-analysis.","volume":"29","author":"Lu","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"R25-20250217","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s12020-024-03919-9","article-title":"Mendelian randomization study of inflammatory bowel disease and type 1 diabetes.","volume":"86","author":"Zhu","year":"2024","journal-title":"Endocrine"},{"key":"R26-20250217","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases.","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R27-20250217","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol"},{"key":"R28-20250217","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1073\/pnas.1715590115","article-title":"Revealing the specificity of regulatory T cells in murine autoimmune diabetes.","volume":"115","author":"Spence","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-20250217","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","article-title":"The immunology of type 1 diabetes.","volume":"24","author":"Herold","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R30-20250217","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ibd\/izz305","article-title":"Disease characteristics and severity in patients with inflammatory bowel disease with coexistent diabetes mellitus.","volume":"26","author":"Din","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"R31-20250217","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00125-024-06303-4","article-title":"Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.","volume":"68","author":"Santoso","year":"2024","journal-title":"Diabetologia"},{"key":"R32-20250217","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/ddq078","article-title":"Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.","volume":"19","author":"Wang","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R33-20250217","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2013.01.048","article-title":"Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-\u03b3-induced signaling in human monocytes.","volume":"144","author":"Spalinger","year":"2013","journal-title":"Gastroenterology"},{"key":"R34-20250217","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2337\/db12-0929","article-title":"PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant.","volume":"62","author":"Zheng","year":"2013","journal-title":"Diabetes"},{"key":"R35-20250217","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"R36-20250217","doi-asserted-by":"crossref","first-page":"934695","DOI":"10.3389\/fimmu.2022.934695","article-title":"Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes.","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Front Immunol"},{"key":"R37-20250217","first-page":"32","article-title":"The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into \u201cOld\u201d diseases.","volume":"6","author":"Harsch","year":"2018","journal-title":"Med Sci"},{"key":"R38-20250217","doi-asserted-by":"crossref","first-page":"14650","DOI":"10.3390\/ijms232314650","article-title":"Pathophysiology of type 1 diabetes and gut microbiota role.","volume":"23","author":"Del Chierico","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R39-20250217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-023-03640-z","article-title":"Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis.","volume":"84","author":"Pan","year":"2024","journal-title":"Endocrine"},{"key":"R40-20250217","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/endrev\/bnab025","article-title":"Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus.","volume":"43","author":"Jais","year":"2022","journal-title":"Endocr Rev"},{"key":"R41-20250217","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/microorganisms8040527","article-title":"Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis.","volume":"8","author":"Wang","year":"2020","journal-title":"Microorganisms"},{"key":"R42-20250217","doi-asserted-by":"crossref","first-page":"103908","DOI":"10.1016\/j.ebiom.2022.103908","article-title":"Microbiota and the gut-brain-axis: implications for new therapeutic design in the CNS.","volume":"77","author":"Liu","year":"2022","journal-title":"eBioMedicine"},{"key":"R43-20250217","doi-asserted-by":"crossref","first-page":"101175","DOI":"10.1016\/j.molmet.2021.101175","article-title":"The gutebrain axis: identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders.","volume":"46","author":"Richards","year":"2021","journal-title":"Mol Metab"},{"key":"R44-20250217","doi-asserted-by":"crossref","first-page":"100246","DOI":"10.1016\/j.deman.2024.100246","article-title":"Autoantibodies in type 1 diabetes: prevalence and clinical profiles.","volume":"17","author":"Hazime","year":"2025","journal-title":"Diabetes Epidemiol Manag"},{"key":"R45-20250217","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2337\/dc16-0351","article-title":"Roles of the gut in glucose homeostasis.","volume":"39","author":"Holst","year":"2016","journal-title":"Diabetes Care"},{"key":"R46-20250217","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4239\/wjd.v12.i8.1248","article-title":"Effect of inflammatory bowel disease treatments on patients with diabetes mellitus.","volume":"12","author":"Bower","year":"2021","journal-title":"World J Diabetes"},{"key":"R47-20250217","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.dld.2022.08.017","article-title":"Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. a systematic review with meta-analysis.","volume":"55","author":"Fuschillo","year":"2023","journal-title":"Dig Liver Dis"},{"key":"R48-20250217","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jcmm.13342","article-title":"Metformin protects against intestinal barrier dysfunction via AMPK\u03b11-dependent inhibition of JNK signalling activation.","volume":"22","author":"Deng","year":"2017","journal-title":"J Cell Mol Med"},{"key":"R49-20250217","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/ecco-jcc\/jjw127","article-title":"Inflammatory bowel disease drugs: a focus on autophagy.","volume":"11","author":"Hooper","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R50-20250217","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.2337\/dc18-1578","article-title":"Dipeptidyl peptidase 4 inhibitors and risk of inflammatory bowel disease among patients with type 2 diabetes: a meta-analysis of randomized controlled trials.","volume":"42","author":"Li","year":"2019","journal-title":"Diabetes Care"},{"key":"R51-20250217","doi-asserted-by":"crossref","first-page":"k872","DOI":"10.1136\/bmj.k872","article-title":"Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.","volume":"360","author":"Abrahami","year":"2018","journal-title":"BMJ"},{"key":"R52-20250217","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/ph15121538","article-title":"Pioglitazone has a null association with inflammatory bowel disease in patients with type 2 diabetes mellitus.","volume":"15","author":"Tseng","year":"2022","journal-title":"Pharmaceuticals"},{"key":"R53-20250217","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","article-title":"GLP-1 induces barrier protective expression in Brunner\u02bcs glands and regulates colonic inflammation.","volume":"22","author":"Bang-Berthelsen","year":"2016","journal-title":"Inflamm Bowel Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:01:31Z","timestamp":1739818891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041532","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}